{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.48","value":"82.50"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"title":"Baseline Performance Status for Eating"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.54","value":"95.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"title":"Baseline Performance Status for Speech"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.07","value":"84.44"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"Baseline Performance Status for Diet"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"51.03","value":"45.83"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"title":"Pre-RT Performance Status for Eating"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.00","value":"100.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"title":"Pre-RT Performance Status for Speech"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"49.16","value":"41.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"}],"units":"Participants"}],"title":"Pre-RT Performance Status for Diet"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"45.64","value":"50.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"title":"Post-RT Performance Status for Eating"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.50","value":"93.75"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"title":"Post-RT Performance Status for Speech"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"45.46","value":"40.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"title":"Post-RT Performance Status for Diet"}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"description":"Consists of assessment of three functions (subscales): Normalcy of diet, eating in public, and understandability of speech. The interviewer rates the patient on each scale based on the patient's responses to targeted questions. Scores range from 0-100 (Full performance (100 score), moderate or severe impairment (≤ 50 score)). The higher the score, the better the ability of the patient to function.","dispersionType":"Standard Deviation","groups":[{"description":"Taxotere/Cisplatinum/5-Fluorouracil (TPF) Chemotherapy Followed by Concomitant Cetuximab \\& Radiation Therapy\n\ncetuximab\n\ncisplatin\n\ndocetaxel\n\nfluorouracil\n\ncomputed tomography\n\npositron emission tomography\n\nquality-of-life assessment\n\n3-dimensional conformal radiation therapy\n\nintensity-modulated radiation therapy","id":"OG000","title":"TPFChemotherapy + Concomitant Cetuximab & RT"}],"paramType":"MEAN","populationDescription":"Data was not collected for all participants.","reportingStatus":"POSTED","timeFrame":"Baseline, pre-radiation therapy and post-radiation therapy, up to 2 years","title":"Performance Status Scale for Head and Neck Cancer","type":"SECONDARY","unitOfMeasure":"Score on a scale"}